The leaky pipeline across borders: a cross-sectional analysis of gender parity in radiation oncology in Austria and Switzerland

Clinical Oncology · Published 2026-08-01 · DOI 10.1016/j.clon.2026.104316

Authors (10)

A. Besserer, M. Waltenberger, I. Wetzler, L. Caglayan, S. Mutiara, J. Schaule, B. Flechl, E. Gkika, M. Trommer, A. Fraller

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Besserer, A., Waltenberger, M., Wetzler, I., et al. (2026). The leaky pipeline across borders: a cross-sectional analysis of gender parity in radiation oncology in Austria and Switzerland. Clinical Oncology. https://doi.org/10.1016/j.clon.2026.104316

Related articles

• Women oncologists across 18 Latin American countries: A multinational survey of professional barriers, leadership, and pay equity · Dialogues in Health · 2026 · Cites or is cited by this article
• Supportive Care Is Not Neutral: Antibiotic Exposure and Survival in Glioblastoma · Clinical Oncology · 2026 · Same journal
• RCR Meetings · Clinical Oncology · 2026 · Same journal
• Toward Clinically Meaningful Hippocampal Sparing in Stereotactic Radiosurgery · Clinical Oncology · 2026 · Same journal
• 135 - Prospective Peer Review of Radiotherapy Contours for Patients Receiving Radical Radiotherapy for Primary Lung Cancer at Nottingham University Hospitals NHS Trust: Can We Successfully Implement the 2022 RCR Guidance? · Clinical Oncology · 2026 · Same journal
• Global Clinical Trial Landscape of Immune Checkpoint Inhibitors in Glioblastoma: Current Status and Future Directions · Clinical Oncology · 2026 · Same journal
• 125 - Reducing Paclitaxel-related hypersensitivity reactions on the chemotherapy unit: A Quality Improvement Project · Clinical Oncology · 2026 · Same journal
• AI Conference Journal Ad July Issue_01 · Clinical Oncology · 2026 · Same journal
• 155 - From Evidence to Experience: Real-World Outcomes with Pembrolizumab in adults with untreated metastatic or unresectable recurrent HNSCC whose tumours express PD-L1 with a CPS of 1 or more. · Clinical Oncology · 2026 · Same journal
• Patterns and Predictors of Dying at Home for Adults With Primary Malignant Brain Tumours: A Comprehensive National Cohort Analysis · Clinical Oncology · 2026 · Same journal